aluates Reports

$ 0.0

Automative

Global Circulating Tumor Cells Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-37Y9103

Global Circulating Tumor Cells Market Insights and Forecast to 2028

BUY CHAPTERS

Global Circulating Tumor Cells Market Research Report 2026

Code: QYRE-Auto-37Y9103

Report

2026-01-21

Pages:134

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Menarini Silicon Biosystems

Qiagen (Adnagen)

Advanced Cell Diagnostics

Apocell Inc

Epic Sciences

Greiner Bio One GmbH

Cynvenio

SurExamBio-Tech

Fluxion Biosciences

Ikonisys

Hangzhou Watson Biotech

Biocept

CytoTrack

Guangzhou Wondfo Biotech

Celsee

Clearbridge Biomedics

Angle plc

Circulating Tumor Cells Market Size

The global Circulating Tumor Cells market was valued at US$ 2711 million in 2025 and is anticipated to reach US$ 9775 million by 2032, at a CAGR of 20.4% from 2026 to 2032.

Circulating Tumor Cells Market

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

The circulating tumor cells (CTC) market is gaining significant traction due to its critical role in cancer detection, prognosis, and treatment monitoring. CTCs are cancer cells that have shed from the primary tumor into the bloodstream, offering a minimally invasive method for liquid biopsy. This technology is becoming increasingly important as it enables early detection, real-time disease monitoring, and personalized therapy selection without the need for invasive tissue biopsies. Key drivers include rising cancer incidence globally, advancements in microfluidics and next-generation sequencing, and growing demand for precision medicine solutions.

The market is witnessing innovations in CTC detection and isolation technologies, such as immunomagnetic separation, microfluidic devices, and PCR-based methods, which enhance accuracy and sensitivity. Pharmaceutical and diagnostic companies are heavily investing in research collaborations and clinical trials to integrate CTC analysis into cancer care protocols. Moreover, the integration of artificial intelligence and bioinformatics for interpreting complex CTC data is creating new opportunities for diagnostic and therapeutic advancements. As healthcare systems prioritize early cancer diagnosis and personalized treatment approaches, the adoption of CTC-based diagnostics is expected to grow significantly across clinical and research applications.

This report delivers a comprehensive overview of the global Circulating Tumor Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Circulating Tumor Cells. The Circulating Tumor Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Circulating Tumor Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Circulating Tumor Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Circulating Tumor Cells Market Report

Report Metric	Details
Report Name	Circulating Tumor Cells Market
Accounted market size in 2025	US$ 2711 million
Forecasted market size in 2032	US$ 9775 million
CAGR	20.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	CTC Enrichment CTC Detection CTC Analysis
Segment by Application	Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, CytoTrack, Guangzhou Wondfo Biotech, Celsee, Clearbridge Biomedics, ANGLE plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Circulating Tumor Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Circulating Tumor Cells Market growing?

Ans: The Circulating Tumor Cells Market witnessing a CAGR of 20.4% during the forecast period 2026-2032.

What is the Circulating Tumor Cells Market size in 2032?

Ans: The Circulating Tumor Cells Market size in 2032 will be US$ 9775 million.

Who are the main players in the Circulating Tumor Cells Market report?

Ans: The main players in the Circulating Tumor Cells Market are Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, CytoTrack, Guangzhou Wondfo Biotech, Celsee, Clearbridge Biomedics, ANGLE plc

What are the Application segmentation covered in the Circulating Tumor Cells Market report?

Ans: The Applications covered in the Circulating Tumor Cells Market report are Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Circulating Tumor Cells Market report?

Ans: The Types covered in the Circulating Tumor Cells Market report are CTC Enrichment, CTC Detection, CTC Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 CTC Enrichment

1.2.3 CTC Detection

1.2.4 CTC Analysis

1.3 Market by Application

1.3.1 Global Circulating Tumor Cells Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Lung Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Circulating Tumor Cells Market Perspective (2021–2032)

2.2 Global Circulating Tumor Cells Growth Trends by Region

2.2.1 Global Circulating Tumor Cells Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Circulating Tumor Cells Historic Market Size by Region (2021–2026)

2.2.3 Circulating Tumor Cells Forecasted Market Size by Region (2027–2032)

2.3 Circulating Tumor Cells Market Dynamics

2.3.1 Circulating Tumor Cells Industry Trends

2.3.2 Circulating Tumor Cells Market Drivers

2.3.3 Circulating Tumor Cells Market Challenges

2.3.4 Circulating Tumor Cells Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Circulating Tumor Cells Players by Revenue

3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2021–2026)

3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2021–2026)

3.2 Global Top Circulating Tumor Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Circulating Tumor Cells Revenue

3.4 Global Circulating Tumor Cells Market Concentration Ratio

3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2025

3.5 Global Key Players of Circulating Tumor Cells Head Offices and Areas Served

3.6 Global Key Players of Circulating Tumor Cells, Products and Applications

3.7 Global Key Players of Circulating Tumor Cells, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Circulating Tumor Cells Breakdown Data by Type

4.1 Global Circulating Tumor Cells Historic Market Size by Type (2021–2026)

4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2027–2032)

5 Circulating Tumor Cells Breakdown Data by Application

5.1 Global Circulating Tumor Cells Historic Market Size by Application (2021–2026)

5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Circulating Tumor Cells Market Size (2021–2032)

6.2 North America Circulating Tumor Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Circulating Tumor Cells Market Size by Country (2021–2026)

6.4 North America Circulating Tumor Cells Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Circulating Tumor Cells Market Size (2021–2032)

7.2 Europe Circulating Tumor Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Circulating Tumor Cells Market Size by Country (2021–2026)

7.4 Europe Circulating Tumor Cells Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Circulating Tumor Cells Market Size (2021–2032)

8.2 Asia-Pacific Circulating Tumor Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region (2021–2026)

8.4 Asia-Pacific Circulating Tumor Cells Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Circulating Tumor Cells Market Size (2021–2032)

9.2 Latin America Circulating Tumor Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Circulating Tumor Cells Market Size by Country (2021–2026)

9.4 Latin America Circulating Tumor Cells Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Circulating Tumor Cells Market Size (2021–2032)

10.2 Middle East & Africa Circulating Tumor Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country (2021–2026)

10.4 Middle East & Africa Circulating Tumor Cells Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Menarini-Silicon Biosystems

11.1.1 Menarini-Silicon Biosystems Company Details

11.1.2 Menarini-Silicon Biosystems Business Overview

11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction

11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2021–2026)

11.1.5 Menarini-Silicon Biosystems Recent Development

11.2 Qiagen (Adnagen)

11.2.1 Qiagen (Adnagen) Company Details

11.2.2 Qiagen (Adnagen) Business Overview

11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction

11.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2021–2026)

11.2.5 Qiagen (Adnagen) Recent Development

11.3 Advanced Cell Diagnostics

11.3.1 Advanced Cell Diagnostics Company Details

11.3.2 Advanced Cell Diagnostics Business Overview

11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction

11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2021–2026)

11.3.5 Advanced Cell Diagnostics Recent Development

11.4 ApoCell

11.4.1 ApoCell Company Details

11.4.2 ApoCell Business Overview

11.4.3 ApoCell Circulating Tumor Cells Introduction

11.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2021–2026)

11.4.5 ApoCell Recent Development

11.5 Epic Sciences

11.5.1 Epic Sciences Company Details

11.5.2 Epic Sciences Business Overview

11.5.3 Epic Sciences Circulating Tumor Cells Introduction

11.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2021–2026)

11.5.5 Epic Sciences Recent Development

11.6 Greiner Bio-one GmbH

11.6.1 Greiner Bio-one GmbH Company Details

11.6.2 Greiner Bio-one GmbH Business Overview

11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction

11.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2021–2026)

11.6.5 Greiner Bio-one GmbH Recent Development

11.7 Cynvenio

11.7.1 Cynvenio Company Details

11.7.2 Cynvenio Business Overview

11.7.3 Cynvenio Circulating Tumor Cells Introduction

11.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2021–2026)

11.7.5 Cynvenio Recent Development

11.8 SurExamBio-Tech

11.8.1 SurExamBio-Tech Company Details

11.8.2 SurExamBio-Tech Business Overview

11.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction

11.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2021–2026)

11.8.5 SurExamBio-Tech Recent Development

11.9 Fluxion Biosciences

11.9.1 Fluxion Biosciences Company Details

11.9.2 Fluxion Biosciences Business Overview

11.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction

11.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2021–2026)

11.9.5 Fluxion Biosciences Recent Development

11.10 Ikonisys

11.10.1 Ikonisys Company Details

11.10.2 Ikonisys Business Overview

11.10.3 Ikonisys Circulating Tumor Cells Introduction

11.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2021–2026)

11.10.5 Ikonisys Recent Development

11.11 Hangzhou Watson Biotech

11.11.1 Hangzhou Watson Biotech Company Details

11.11.2 Hangzhou Watson Biotech Business Overview

11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction

11.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2021–2026)

11.11.5 Hangzhou Watson Biotech Recent Development

11.12 Biocept

11.12.1 Biocept Company Details

11.12.2 Biocept Business Overview

11.12.3 Biocept Circulating Tumor Cells Introduction

11.12.4 Biocept Revenue in Circulating Tumor Cells Business (2021–2026)

11.12.5 Biocept Recent Development

11.13 CytoTrack

11.13.1 CytoTrack Company Details

11.13.2 CytoTrack Business Overview

11.13.3 CytoTrack Circulating Tumor Cells Introduction

11.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2021–2026)

11.13.5 CytoTrack Recent Development

11.14 Guangzhou Wondfo Biotech

11.14.1 Guangzhou Wondfo Biotech Company Details

11.14.2 Guangzhou Wondfo Biotech Business Overview

11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction

11.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2021–2026)

11.14.5 Guangzhou Wondfo Biotech Recent Development

11.15 Celsee

11.15.1 Celsee Company Details

11.15.2 Celsee Business Overview

11.15.3 Celsee Circulating Tumor Cells Introduction

11.15.4 Celsee Revenue in Circulating Tumor Cells Business (2021–2026)

11.15.5 Celsee Recent Development

11.16 Clearbridge Biomedics

11.16.1 Clearbridge Biomedics Company Details

11.16.2 Clearbridge Biomedics Business Overview

11.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction

11.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2021–2026)

11.16.5 Clearbridge Biomedics Recent Development

11.17 ANGLE plc

11.17.1 ANGLE plc Company Details

11.17.2 ANGLE plc Business Overview

11.17.3 ANGLE plc Circulating Tumor Cells Introduction

11.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2021–2026)

11.17.5 ANGLE plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Menarini Silicon Biosystems

Qiagen (Adnagen)

Advanced Cell Diagnostics

Apocell Inc

Epic Sciences

Greiner Bio One GmbH

Cynvenio

SurExamBio-Tech

Fluxion Biosciences

Ikonisys

Hangzhou Watson Biotech

Biocept

CytoTrack

Guangzhou Wondfo Biotech

Celsee

Clearbridge Biomedics

Angle plc

List of Tables

Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of CTC Enrichment

Table 3. Key Players of CTC Detection

Table 4. Key Players of CTC Analysis

Table 5. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Circulating Tumor Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Circulating Tumor Cells Market Size by Region (US$ Million), 2021–2026

Table 8. Global Circulating Tumor Cells Market Share by Region (2021–2026)

Table 9. Global Circulating Tumor Cells Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Circulating Tumor Cells Market Share by Region (2027–2032)

Table 11. Circulating Tumor Cells Market Trends

Table 12. Circulating Tumor Cells Market Drivers

Table 13. Circulating Tumor Cells Market Challenges

Table 14. Circulating Tumor Cells Market Restraints

Table 15. Global Circulating Tumor Cells Revenue by Players (US$ Million), 2021–2026

Table 16. Global Circulating Tumor Cells Market Share by Players (2021–2026)

Table 17. Global Top Circulating Tumor Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Circulating Tumor Cells Revenue, 2025

Table 18. Ranking of Global Top Circulating Tumor Cells Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Circulating Tumor Cells, Headquarters and Area Served

Table 21. Global Key Players of Circulating Tumor Cells, Products and Applications

Table 22. Global Key Players of Circulating Tumor Cells, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Circulating Tumor Cells Market Size by Type (US$ Million), 2021–2026

Table 25. Global Circulating Tumor Cells Revenue Market Share by Type (2021–2026)

Table 26. Global Circulating Tumor Cells Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Circulating Tumor Cells Revenue Market Share by Type (2027–2032)

Table 28. Global Circulating Tumor Cells Market Size by Application (US$ Million), 2021–2026

Table 29. Global Circulating Tumor Cells Revenue Market Share by Application (2021–2026)

Table 30. Global Circulating Tumor Cells Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Circulating Tumor Cells Revenue Market Share by Application (2027–2032)

Table 32. North America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Circulating Tumor Cells Market Size by Country (US$ Million), 2021–2026

Table 34. North America Circulating Tumor Cells Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Circulating Tumor Cells Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Circulating Tumor Cells Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Circulating Tumor Cells Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Circulating Tumor Cells Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Circulating Tumor Cells Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Circulating Tumor Cells Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Circulating Tumor Cells Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Circulating Tumor Cells Market Size by Country (US$ Million), 2027–2032

Table 47. Menarini-Silicon Biosystems Company Details

Table 48. Menarini-Silicon Biosystems Business Overview

Table 49. Menarini-Silicon Biosystems Circulating Tumor Cells Product

Table 50. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 51. Menarini-Silicon Biosystems Recent Development

Table 52. Qiagen (Adnagen) Company Details

Table 53. Qiagen (Adnagen) Business Overview

Table 54. Qiagen (Adnagen) Circulating Tumor Cells Product

Table 55. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 56. Qiagen (Adnagen) Recent Development

Table 57. Advanced Cell Diagnostics Company Details

Table 58. Advanced Cell Diagnostics Business Overview

Table 59. Advanced Cell Diagnostics Circulating Tumor Cells Product

Table 60. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 61. Advanced Cell Diagnostics Recent Development

Table 62. ApoCell Company Details

Table 63. ApoCell Business Overview

Table 64. ApoCell Circulating Tumor Cells Product

Table 65. ApoCell Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 66. ApoCell Recent Development

Table 67. Epic Sciences Company Details

Table 68. Epic Sciences Business Overview

Table 69. Epic Sciences Circulating Tumor Cells Product

Table 70. Epic Sciences Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 71. Epic Sciences Recent Development

Table 72. Greiner Bio-one GmbH Company Details

Table 73. Greiner Bio-one GmbH Business Overview

Table 74. Greiner Bio-one GmbH Circulating Tumor Cells Product

Table 75. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 76. Greiner Bio-one GmbH Recent Development

Table 77. Cynvenio Company Details

Table 78. Cynvenio Business Overview

Table 79. Cynvenio Circulating Tumor Cells Product

Table 80. Cynvenio Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 81. Cynvenio Recent Development

Table 82. SurExamBio-Tech Company Details

Table 83. SurExamBio-Tech Business Overview

Table 84. SurExamBio-Tech Circulating Tumor Cells Product

Table 85. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 86. SurExamBio-Tech Recent Development

Table 87. Fluxion Biosciences Company Details

Table 88. Fluxion Biosciences Business Overview

Table 89. Fluxion Biosciences Circulating Tumor Cells Product

Table 90. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 91. Fluxion Biosciences Recent Development

Table 92. Ikonisys Company Details

Table 93. Ikonisys Business Overview

Table 94. Ikonisys Circulating Tumor Cells Product

Table 95. Ikonisys Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 96. Ikonisys Recent Development

Table 97. Hangzhou Watson Biotech Company Details

Table 98. Hangzhou Watson Biotech Business Overview

Table 99. Hangzhou Watson Biotech Circulating Tumor Cells Product

Table 100. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 101. Hangzhou Watson Biotech Recent Development

Table 102. Biocept Company Details

Table 103. Biocept Business Overview

Table 104. Biocept Circulating Tumor Cells Product

Table 105. Biocept Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 106. Biocept Recent Development

Table 107. CytoTrack Company Details

Table 108. CytoTrack Business Overview

Table 109. CytoTrack Circulating Tumor Cells Product

Table 110. CytoTrack Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 111. CytoTrack Recent Development

Table 112. Guangzhou Wondfo Biotech Company Details

Table 113. Guangzhou Wondfo Biotech Business Overview

Table 114. Guangzhou Wondfo Biotech Circulating Tumor Cells Product

Table 115. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 116. Guangzhou Wondfo Biotech Recent Development

Table 117. Celsee Company Details

Table 118. Celsee Business Overview

Table 119. Celsee Circulating Tumor Cells Product

Table 120. Celsee Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 121. Celsee Recent Development

Table 122. Clearbridge Biomedics Company Details

Table 123. Clearbridge Biomedics Business Overview

Table 124. Clearbridge Biomedics Circulating Tumor Cells Product

Table 125. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 126. Clearbridge Biomedics Recent Development

Table 127. ANGLE plc Company Details

Table 128. ANGLE plc Business Overview

Table 129. ANGLE plc Circulating Tumor Cells Product

Table 130. ANGLE plc Revenue in Circulating Tumor Cells Business (US$ Million), 2021–2026

Table 131. ANGLE plc Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Circulating Tumor Cells Picture

Figure 2. Global Circulating Tumor Cells Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Circulating Tumor Cells Market Share by Type: 2025 vs 2032

Figure 4. CTC Enrichment Features

Figure 5. CTC Detection Features

Figure 6. CTC Analysis Features

Figure 7. Global Circulating Tumor Cells Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Circulating Tumor Cells Market Share by Application: 2025 vs 2032

Figure 9. Breast Cancer Case Studies

Figure 10. Prostate Cancer Case Studies

Figure 11. Colorectal Cancer Case Studies

Figure 12. Lung Cancer Case Studies

Figure 13. Others Case Studies

Figure 14. Circulating Tumor Cells Report Years Considered

Figure 15. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Circulating Tumor Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Circulating Tumor Cells Market Share by Region: 2025 vs 2032

Figure 18. Global Circulating Tumor Cells Market Share by Players in 2025

Figure 19. Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2025

Figure 21. North America Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Circulating Tumor Cells Market Share by Country (2021–2032)

Figure 23. United States Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Circulating Tumor Cells Market Share by Country (2021–2032)

Figure 27. Germany Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Circulating Tumor Cells Market Share by Region (2021–2032)

Figure 35. China Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Circulating Tumor Cells Market Share by Country (2021–2032)

Figure 43. Mexico Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Circulating Tumor Cells Market Share by Country (2021–2032)

Figure 47. Israel Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Circulating Tumor Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 51. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 52. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 53. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 54. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 55. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 56. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 57. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 58. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 59. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 60. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 61. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 62. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 63. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 64. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 65. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 66. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Circulating Tumor Cells CTCs Detectors Market Research Report 2024

Global Circulating Tumor Cell CTC Detector Market Research Report 2024

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2024

Global Free Circulating Tumor Cell Detection Market Research Report 2024

Circulating Tumor Cell CTC Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumor Cell Detection System Market Research Report 2024

Global Circulating Tumor Cells CTCs and Cancer Stem Cells CSCs Market Insights Forecast to 2030

Global Circulating Tumor Cell CTC Detection Market Research Report 2024

Global Circulating Tumor Cell Diagnostics Market Insights Forecast to 2030

Circulating Tumor Cell Capture Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumor Cell Kit Market Research Report 2024

Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumour DNA ctDNA Testing Market Research Report 2024

Global Cell free Tumor DNA Detection Market Research Report 2025

Global Circulating Tumor Cell Detector Market Research Report 2024

Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liquid Biopsy Products Market Insights Forecast to 2030

Global Circulating Tumor DNA Diagnostics Market Research Report 2025

Circulating Tumor Cell Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions